Planned enrollment decreased by 350 participants
Before: 600 participants (planned). After: 250 participants (planned).
Primary completion date changed
Before: 30 Apr 2028. After: Nov 2027.
Study sponsor: Verrica Pharmaceuticals Inc. · VRCA
Primary completion is the date data collection ends for the main study measures, not when results are published.
Before: 600 participants (planned). After: 250 participants (planned).
Before: 30 Apr 2028. After: Nov 2027.
Before: Not yet recruiting. After: Recruiting.